Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Virgo Global Ltd

VIRGOGLOB
BSE
5.91
4.68%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Virgo Global Ltd

VIRGOGLOB
BSE
5.91
4.68%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
6Cr
Close
Close Price
5.91
Industry
Industry
IT - Software
PE
Price To Earnings
PS
Price To Sales
6.75
Revenue
Revenue
1Cr
Rev Gr TTM
Revenue Growth TTM
-80.51%
PAT Gr TTM
PAT Growth TTM
-74.44%
Peer Comparison
How does VIRGOGLOB stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
VIRGOGLOB
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue
RevenueCr
1037241440000001
Growth YoY
Revenue Growth YoY%
52.5377.4134.5-24.0-53.5-99.3-100.0-100.0-100.0-100.0
Expenses
ExpensesCr
10382413510-10100
Operating Profit
Operating ProfitCr
0-1100-1010-101
OPM
OPM%
0.6-1.92.52.3-5.2-356.089.1
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0-1100-1010-101
Tax
TaxCr
000000000000
PAT
PATCr
0-1100-1010-101
Growth YoY
PAT Growth YoY%
107.1-180.21,450.0875.0-560.0-21.9-164.5100.017.414.672.532.3
NPM
NPM%
0.5-1.92.62.3-5.2-356.089.1
EPS
EPS
0.1-0.70.60.3-0.2-0.7-0.40.6-0.2-0.7-0.10.8

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
00176391316428541
Growth
Revenue Growth%
3.429.01,253.3448.2808.5-85.645.118.1173.6100.0-94.7-79.4
Expenses
ExpensesCr
00176391315428541
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
-20.3-139.7-1.3-0.30.21.10.30.70.90.31.4-25.0
Other Income
Other IncomeCr
00000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth
PAT Growth%
-44.8-4,084.2101.516.8373.4-81.7172.8381.4146.48.7-98.7-7,766.7
NPM
NPM%
15.1-465.80.50.10.10.10.10.60.50.30.1-25.0
EPS
EPS
0.0-0.40.00.00.00.00.00.10.20.20.0-0.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
444444444444
Reserves
ReservesCr
-4-4-4-4-4-4-4-4-4-3-3-4
Current Liabilities
Current LiabilitiesCr
00001633413588
Non Current Liabilities
Non Current LiabilitiesCr
233100013300
Total Liabilities
Total LiabilitiesCr
23311633516998
Current Assets
Current AssetsCr
23311633516998
Non Current Assets
Non Current AssetsCr
000000000000
Total Assets
Total AssetsCr
23311633516998

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
0-102100-1-1-1525
Investing Cash Flow
Investing Cash FlowCr
010000000-1,6530
Financing Cash Flow
Financing Cash FlowCr
000-2-10012-2-25
Net Cash Flow
Net Cash FlowCr
000000001-1,6700
Free Cash Flow
Free Cash FlowCr
0-102100-1-1-1525
CFO To PAT
CFO To PAT%
271.9157.2-1,455.520,318.73,769.8-641.9635.1-689.7-437.0-6,233.28,42,800.0
CFO To EBITDA
CFO To EBITDA%
-201.8523.9575.4-9,133.6986.8-43.0349.9-536.6-260.1-5,514.940,133.3

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
121041009964
Price To Earnings
Price To Earnings
79.00.087.034.0101.867.00.00.041.336.00.0-16.9
Price To Sales
Price To Sales
11.926.10.70.10.10.10.00.00.20.11.34.2
Price To Book
Price To Book
1.312.44.81.818.52.90.00.016.110.77.16.8
EV To EBITDA
EV To EBITDA
-28.7-33.4-179.2-51.425.81.0-21.4-0.927.141.088.8-16.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.0100.0100.028.19.916.5100.0
OPM
OPM%
-20.3-139.7-1.3-0.30.21.10.30.70.90.31.4-25.0
NPM
NPM%
15.1-465.80.50.10.10.10.10.60.50.30.1-25.0
ROCE
ROCE%
2.7-16.10.40.929.14.19.913.712.410.67.9-40.4
ROE
ROE%
1.8-236.73.53.915.72.87.125.438.529.50.4-40.4
ROA
ROA%
0.4-15.70.20.60.20.20.52.01.42.80.0-2.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Virgo Global Limited is an Indian listed entity headquartered in **Hyderabad, Telangana**. The company operates a diversified business model spanning **Information Technology (IT)**, **E-commerce**, and **Consumer Goods**, with broad corporate objects that allow for expansion into real estate and agriculture. Currently, the company is undergoing a significant **financial restructuring** via a **Capital Reduction Scheme** to address historical losses and reposition itself for future growth. --- ### **Diversified Business Verticals & Service Portfolio** Virgo Global Limited maintains a multi-sectoral operational framework. As of **February 2025**, the company reports its financials under a **single reportable segment** as defined by **Ind AS 108**, though its capabilities span several distinct industries: * **IT & Software Solutions:** * Comprehensive software design, development, customization, and maintenance. * **IT Enabled Services (ITES)**, including medical transcription, data processing, and web-based solutions. * Hardware trading, assembly of data processors, and networking management. * **Data Centre** services and internet/web-based application hosting. * **E-commerce & Digital Marketing:** * Online and offline trading of consumer goods utilizing **Multi-Level Marketing (MLM)** and virtual malls. * **Business-to-Business (B2B)** and **Business-to-Consumer (B2C)** net commerce solutions. * Digital infrastructure services including electronic data interchange (**EDI**), enhanced telefax, and secure payment processing. * **Pharmaceuticals & Healthcare:** * Manufacturing, distribution, and trading of drugs, intermediates, vaccines, and **nutraceuticals**. * Wholesale and retail trade of surgical equipment, medical devices, and ayurvedic products. * Consultancy for pharma manufacturing, medical writing, and data mining. * **Real Estate & Infrastructure:** * Development of residential and commercial complexes for sale or rental income. * Civil contracting for public works including roads, bridges, and water supply systems. * **Agriculture & Allied Activities:** * Horticulture, sericulture, and dairy farming. * Production and trading of food grains, seeds, and vegetable oils. --- ### **Strategic Financial Restructuring: Capital Reduction 2026** The company’s primary strategic focus is the restoration of its financial health. In **April 2026**, the Board of Directors approved a **Scheme of Reduction of Capital** to address a significant mismatch between the company's paid-up share capital and the actual realizable value of its assets. **The Mechanism:** The company is setting off **accumulated losses** against its paid-up equity share capital. This is a non-cash accounting restructuring designed to "clean" the balance sheet. | Metric | Pre-Reduction Status | Post-Reduction (Indicative) | | :--- | :--- | :--- | | **Paid-up Capital** | **Rs. 4,20,17,200** | **Rs. 58,82,408** | | **Total Equity Shares** | **1,05,04,300** | **14,70,602** | | **Face Value per Share** | **Rs. 4/-** | **Rs. 4/-** | | **Reduction Percentage** | **-** | **86%** | | **Shares Extinguished** | **-** | **90,33,698** | **Strategic Objectives:** * **Balance Sheet Correction:** Extinguish the debit balance of accumulated losses to present a healthier financial position to stakeholders. * **Capital Market Access:** Restore credibility to approach financial institutions for **debt and equity financing** on commercially viable terms. * **Growth Enablement:** Remove structural impediments to the deployment of **working capital**. * **Private Placement:** Facilitate the raising of fresh capital through **private placements** once the balance sheet is right-sized. --- ### **Historical Financial Performance & Net Worth Analysis** The company’s financial position has been characterized by significant **accumulated losses** and an erosion of **net worth** due to adverse market conditions. **Five-Year Financial Summary:** | Financial Year | Profits / (Losses) (Rs.) | Accumulated Losses (Rs.) | Net Worth (Rs.) | | :--- | :--- | :--- | :--- | | **2021-22** | **8,88,604** | **(3,85,22,817)** | **34,94,383** | | **2022-23** | **21,91,174** | **(3,63,31,643)** | **56,85,557** | | **2023-24** | **23,80,000** | **(3,39,60,000)** | **80,57,200** | | **2024-25** | **30,000** | **(3,39,20,000)** | **80,97,200** | | **2025-26** | **(23,28,856)** | **(3,62,51,345)** | **57,65,855** | **Key Financial Policies:** * **Dividend Policy:** The company has **not declared any dividends** in recent years, opting for the **conservation of profits** to address financial instability. * **Authorized Capital:** Remains at **Rs. 13,00,00,000** divided into **3,25,00,000** equity shares of **Rs. 4/-** each. * **Compliance:** Financials are prepared in accordance with **Ind AS** notified by the Ministry of Corporate Affairs. --- ### **Corporate Governance & Operational Infrastructure** The company operates from its registered office in **Vikrampuri Colony, Kakaguda, Hyderabad**. Governance is managed by a Board of Directors supported by three mandatory statutory committees: | Committee | Composition | Key Responsibility | | :--- | :--- | :--- | | **Audit Committee** | **3 Members** (Majority Independent) | Financial oversight and internal controls | | **Nomination & Remuneration** | **3 Members** (All Non-Executive) | Director appointments and compensation | | **Stakeholders Relationship** | **3 Members** (Majority Independent) | Investor grievance and relations | --- ### **Market Outlook & Growth Drivers** Virgo Global Limited’s long-term strategy is centered on leveraging favorable demographics and expanding its distribution reach: * **Distribution Network:** Continuous focus on increasing the **product basket** and strengthening reach across India. * **Macro Drivers:** Capitalizing on **increasing urbanization** and rising **disposable income** in the Indian market. * **Geographic Strategy:** * **Emerging Economies:** Focus on aggressive growth and **new product launches**. * **Mature Economies:** Targeting **higher profitability** and stable **cash flow generation**. --- ### **Risk Management & Mitigation Framework** The company identifies several systemic and operational risks that could impact future performance: * **Market Volatility**: Sensitivity to **global and Indian demand-supply conditions** and fluctuations in **finished goods prices**. * **Financial Constraints**: Until the **Capital Reduction Scheme** (scheduled for shareholder approval on **May 15, 2026**) is finalized, the company remains limited by its inability to access traditional institutional finance. * **Regulatory Risks**: Potential impacts from changes in **Government regulations**, **tax regimes**, and **securities law compliance**. * **Operational Risks**: Dependence on the **availability and pricing of feeds** and potential **labour negotiations** or **litigation**. | Risk Category | Primary Drivers | | :--- | :--- | | **Market Risk** | Price volatility; demand-supply imbalances; cyclicality. | | **Operational Risk** | Feedstock availability; supply chain disruptions; industrial relations. | | **Regulatory Risk** | Changes in Indian/International tax laws; NCLT approval timelines. | | **External Risk** | Macroeconomic downturns; geopolitical instability. |